Pathogenesis of psoriasis in the "omic" era. Part IV. Epidemiology, genetics, immunopathogenesis, clinical manifestation and treatment of psoriatic arthritis
Copyright © 2020 Termedia..
Psoriatic arthritis (PsA) is a chronic, progressive, inflammatory arthropathy associated with psoriasis as well as a complex pathogenesis. Genetic and environmental factors trigger the development of the immune-mediated auto-inflammatory response in different sites: skin, bone marrow, entheses and synovial tissues. Studies of the last two decades have changed the view of PsA from a mild, non-progressive arthritis to an inflammatory systemic disease with serious health consequences, not only associated with joint dysfunction, but also with an increased risk of cardiovascular disease and socioeconomic consequences with significantly reduced quality of life. The joint damage starts early in the course of the disease, thus early recognition and treatment with modern biological treatments, which may modify the natural history and slow down progression of this debilitating disease, is essential for the patient long-term outcome.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Postepy dermatologii i alergologii - 37(2020), 5 vom: 30. Okt., Seite 625-634 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Szczerkowska-Dobosz, Aneta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Classification |
|---|
| Anmerkungen: |
Date Revised 27.11.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5114/ada.2020.100478 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318065746 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318065746 | ||
| 003 | DE-627 | ||
| 005 | 20231225164558.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5114/ada.2020.100478 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318065746 | ||
| 035 | |a (NLM)33239999 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Szczerkowska-Dobosz, Aneta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pathogenesis of psoriasis in the "omic" era. Part IV. Epidemiology, genetics, immunopathogenesis, clinical manifestation and treatment of psoriatic arthritis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.11.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2020 Termedia. | ||
| 520 | |a Psoriatic arthritis (PsA) is a chronic, progressive, inflammatory arthropathy associated with psoriasis as well as a complex pathogenesis. Genetic and environmental factors trigger the development of the immune-mediated auto-inflammatory response in different sites: skin, bone marrow, entheses and synovial tissues. Studies of the last two decades have changed the view of PsA from a mild, non-progressive arthritis to an inflammatory systemic disease with serious health consequences, not only associated with joint dysfunction, but also with an increased risk of cardiovascular disease and socioeconomic consequences with significantly reduced quality of life. The joint damage starts early in the course of the disease, thus early recognition and treatment with modern biological treatments, which may modify the natural history and slow down progression of this debilitating disease, is essential for the patient long-term outcome | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a classification | |
| 650 | 4 | |a genetics | |
| 650 | 4 | |a immunopathogenesis | |
| 650 | 4 | |a psoriatic arthritis | |
| 650 | 4 | |a treatment | |
| 700 | 1 | |a Krasowska, Dorota |e verfasserin |4 aut | |
| 700 | 1 | |a Bartosińska, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Stawczyk-Macieja, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Walczak, Aleksandra |e verfasserin |4 aut | |
| 700 | 1 | |a Owczarczyk-Saczonek, Agnieszka |e verfasserin |4 aut | |
| 700 | 1 | |a Reich, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Batycka-Baran, Aleksandra |e verfasserin |4 aut | |
| 700 | 1 | |a Czajkowski, Rafał |e verfasserin |4 aut | |
| 700 | 1 | |a Dobrucki, Iwona T |e verfasserin |4 aut | |
| 700 | 1 | |a Dobrucki, Lawrence W |e verfasserin |4 aut | |
| 700 | 1 | |a Górecka-Sokołowska, Magdalena |e verfasserin |4 aut | |
| 700 | 1 | |a Janaszak-Jasiecka, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Kalinowski, Leszek |e verfasserin |4 aut | |
| 700 | 1 | |a Nowicki, Roman J |e verfasserin |4 aut | |
| 700 | 1 | |a Płoska, Agata |e verfasserin |4 aut | |
| 700 | 1 | |a Purzycka-Bohdan, Dorota |e verfasserin |4 aut | |
| 700 | 1 | |a Radulska, Adrianna |e verfasserin |4 aut | |
| 700 | 1 | |a Reszka, Edyta |e verfasserin |4 aut | |
| 700 | 1 | |a Samotij, Dominik |e verfasserin |4 aut | |
| 700 | 1 | |a Siekierzycka, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Slominski, Andrzej T |e verfasserin |4 aut | |
| 700 | 1 | |a Slominski, Radomir M |e verfasserin |4 aut | |
| 700 | 1 | |a Sobalska-Kwapis, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Strapagiel, Dominik |e verfasserin |4 aut | |
| 700 | 1 | |a Szczęch, Justyna |e verfasserin |4 aut | |
| 700 | 1 | |a Żmijewski, Michał A |e verfasserin |4 aut | |
| 700 | 1 | |a Nedoszytko, Bogusław |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Postepy dermatologii i alergologii |d 2013 |g 37(2020), 5 vom: 30. Okt., Seite 625-634 |w (DE-627)NLM233086382 |x 1642-395X |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2020 |g number:5 |g day:30 |g month:10 |g pages:625-634 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5114/ada.2020.100478 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2020 |e 5 |b 30 |c 10 |h 625-634 | ||